GOSS stock

Gossamer Bio Inc (GOSS) financials · rev $48.5M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Gossamer Bio Inc (GOSS) rev $48.5M.

Cached annual income statement
LineFY2025FY2024
Revenue$48.5M$114.7M
Operating Income-$170.7M-$59.9M
Net Income-$170.4M-$56.5M
EPS (Diluted)-$0.75-$0.25
Cached annual balance sheet
LineFY2025FY2024
Total Assets$172.2M$315.3M
Current Assets$167.6M$309.9M
Cash & Equivalents$37.7M$46.1M
PP&E$64.0K$10.0K
Total Liabilities$295.0M$285.8M
Current Liabilities$63.4M$45.0M
Short-term DebtN/AN/A
Long-term DebtN/AN/A
Shareholders' Equity-$122.8M$29.5M
Retained Earnings-$1.44B-$1.27B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$171.3M-$3.47M
CapEx$79.0KN/A
Investing Cash Flow$156.4M$29.0M
Financing Cash Flow$6.42M-$11.5M
Net Change in Cash-$8.34M$14.0M
Free Cash Flow-$171.3M-$3.47M
These statements as JSON? API free 100/day

FAQ

What is GOSS P/E and revenue?

Gossamer Bio Inc (GOSS) rev $48.5M.

What is GOSS revenue?

Gossamer Bio Inc last cached revenue is $48.5M (FY2025).

Is GOSS profitable?

Gossamer Bio Inc last cached net income is -$170.4M (FY2025).

What are GOSS total assets?

Gossamer Bio Inc last cached total assets are $172.2M (FY2025).

What is GOSS free cash flow?

Gossamer Bio Inc last cached free cash flow is -$171.3M (FY2025).

Not investment advice. Cached statements, not a live tape.